Innovations In Clinical Neuroscience

JAN-FEB 2018

A peer-reviewed, evidence-based journal for clinicians in the field of neuroscience

Issue link:

Contents of this Issue


Page 0 of 53

I N N O V A T I O N S I N C L I N I C A L N E U R O S C I E N C E The official journal of I S C D D The international Society for CNS Drug Development I C N S VOL. 15, NO. 1–2 • JANUARY–FEBRUARY 2018 INNOVATIONSCNS.COM PEER-REVIEWED • EVIDENCE-BASED • INDEXED ON PUBMED CENTRAL PIMAVANSERIN: A NOVEL DRUG Approved to Treat Parkinson's Disease Psychosis EFFECTIVENESS OF ELECTROCONVULSIVE THERAPY (ECT) in Parkinsonian Symptoms: A Case Series LOWER-EXTREMITY DYNAMOMETRY as a Novel Outcome Measure in a Double-blind, Placebo- controlled, Feasibility Trial of Intravenous Immunoglobulin (IVIG) for HIV-associated Myelopathy THE BENEFIT OF MIRTAZAPINE in the Treatment of Progressive Multifocal Leukoencephalopathy in a Young HIV-positive Patient: A Case Report COGNITIVE IMPAIRMENT Associated with Cancer: A Brief Review WANTS TALK PSYCHOTHERAPY but Cannot Talk: EMDR for Post-stroke Depression with Expressive Aphasia "VETTING" SERVICE DOGS and Emotional Support Animals Follow us.

Articles in this issue

Links on this page

Archives of this issue

view archives of Innovations In Clinical Neuroscience - JAN-FEB 2018